{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:13:47Z","timestamp":1794446027265,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N025792\/1"],"award-info":[{"award-number":["MR\/N025792\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["115952"],"award-info":[{"award-number":["115952"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["MR\/M024717"],"award-info":[{"award-number":["MR\/M024717"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"crossref","award":["ARUK-SRF2017B-1"],"award-info":[{"award-number":["ARUK-SRF2017B-1"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Senior Investigator Award"},{"name":"Edmond J Safra Foundation and Lily Safra"},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07885-4","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:29:25Z","timestamp":1777429765000},"page":"5110-5129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Dementias Platform UK PET\/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3114-0773","authenticated-orcid":false,"given":"Pawel J.","family":"Markiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Wardlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Wimberley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Paul","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Firbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Hoggard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hillel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Rhodes-Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin I.","family":"Aigbirhio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Grey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgios","family":"Krokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Mackewn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Herholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"1","key":"7885_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cpet.2024.09.008","volume":"20","author":"A Flaus","year":"2025","unstructured":"Flaus A, Guedj E, Horowitz T, Semah F, Verger A, Hammers A. Brain PET imaging in the presurgical evaluation of drug-resistant focal epilepsy. PET Clinics. 2025;20(1):57\u201366. https:\/\/doi.org\/10.1016\/j.cpet.2024.09.008.","journal-title":"PET Clinics"},{"issue":"12","key":"7885_CR2","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1007\/s00259-025-07366-0","volume":"52","author":"MJ Mair","year":"2025","unstructured":"Mair MJ, Lohmann P, Galldiks N, Belting M, Brandal P, Broen MPG, et al. Availability and use of PET in patients with brain tumours \u2013 a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey. Eur J Nucl Med Mol Imaging. 2025;52(12):4627\u201338. https:\/\/doi.org\/10.1007\/s00259-025-07366-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"7885_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1177\/0271678X20910038","volume":"40","author":"CY Sander","year":"2020","unstructured":"Sander CY, Hansen HD, Wey H-Y. Advances in simultaneous PET\/MR for imaging neuroreceptor function. J Cerebral Blood Flow Metabol. 2020;40(6):1148\u201366. https:\/\/doi.org\/10.1177\/0271678X20910038.","journal-title":"J Cerebral Blood Flow Metabol"},{"issue":"2","key":"7885_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.mric.2017.01.002","volume":"25","author":"C Catana","year":"2017","unstructured":"Catana C. Principles of simultaneous PET\/MR imaging. Magn Reson Imaging Clin N Am. 2017;25(2):231\u201343. https:\/\/doi.org\/10.1016\/j.mric.2017.01.002.","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"1","key":"7885_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/mds.27877","volume":"35","author":"N Pyatigorskaya","year":"2020","unstructured":"Pyatigorskaya N, Yahia-Cherif L, Gaurav R, Ewenczyk C, Gallea C, Valabregue R, et al. Multimodal magnetic resonance imaging quantification of brain changes in progressive supranuclear palsy. Mov Disord. 2020;35(1):161\u201370. https:\/\/doi.org\/10.1002\/mds.27877.","journal-title":"Mov Disord"},{"key":"7885_CR6","doi-asserted-by":"publisher","unstructured":"Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci. 2018;19(11):687\u2013700. https:\/\/doi.org\/10.1038\/s41583-018-0067-3. Publisher: Nature Publishing Group. Accessed 19 Aug 2025.","DOI":"10.1038\/s41583-018-0067-3"},{"key":"7885_CR7","doi-asserted-by":"publisher","unstructured":"Villemagne VL, Barkhof F, Garibotto V, Landau SM, Nordberg A, Berckel BNMv. Molecular imaging approaches in dementia. Radiology. 2021. https:\/\/doi.org\/10.1148\/radiol.2020200028. Publisher: Radiological Society of North America. Accessed 24 Mar 2025","DOI":"10.1148\/radiol.2020200028"},{"issue":"1","key":"7885_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, Arnim CAF, Burnie N, Bozeat S, Cummings J. Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants. Alzheimer\u2019s Res Therapy. 2023;15(1):175. https:\/\/doi.org\/10.1186\/s13195-023-01314-6.","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"7","key":"7885_CR9","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00259-025-07135-z","volume":"52","author":"M Rullmann","year":"2025","unstructured":"Rullmann M, Henssen D, Melasch JT, Scherlach C, Saur D, Schroeter ML, et al. for the German imaging initiative for tauopathies (GII4T): Multi-parametric [18F]PI-2620 tau PET\/MRI for the phenotyping of different Alzheimer\u2019s disease variants. Eur J Nucl Med Mol Imaging. 2025;52(7):2279\u201389. https:\/\/doi.org\/10.1007\/s00259-025-07135-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7885_CR10","doi-asserted-by":"publisher","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A$$\\beta $$ plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136. https:\/\/doi.org\/10.1038\/nature19323. Publisher: Nature Publishing Group. Accessed 04 Jan 2026.","DOI":"10.1038\/nature19323"},{"key":"7885_CR11","doi-asserted-by":"publisher","unstructured":"Jack\u00a0Jr CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors, Elliott C, Masliah E, Ryan L, Silverberg N. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia. 2018;14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","DOI":"10.1016\/j.jalz.2018.02.018"},{"issue":"10","key":"7885_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamaneurol.2022.2793","volume":"79","author":"S Shcherbinin","year":"2022","unstructured":"Shcherbinin S, Evans CD, Lu M, Andersen SW, Pontecorvo MJ, Willis BA, et al. Association of amyloid reduction after donanemab treatment with tau pathology and clinical outcomes: the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol. 2022;79(10):1015\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2022.2793.","journal-title":"JAMA Neurol"},{"key":"7885_CR13","doi-asserted-by":"publisher","unstructured":"Dyck CHv, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","DOI":"10.1056\/NEJMoa2212948"},{"key":"7885_CR14","doi-asserted-by":"publisher","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul\u00a0Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM, TRAILBLAZER-ALZ 2 Investigators, Abreu R, Agarwal P, Aggarwal P, Agronin M, Allen A, Altamirano D, Alva G, Andersen J, Anderson A, Anderson D, Arnold J, Asada T, Aso Y, Atit V, Ayala R, Badruddoja M, Badzio-jagiello H, Bajacek M, Barton D, Bear D, Benjamin S, Bergeron R, Bhatia P, Black S, Block A, Bolouri M, Bond W, Bouthillier J, Brangman S, Brew B, Brisbin S, Brisken T, Brodtmann A, Brody M, Brosch J, Brown C, Brownstone P, Bukowczan S, Burns J, Cabrera A, Capote H, Carrasco A, Cevallos\u00a0Yepez J, Chavez E, Chertkow H, Chyrchel-paszkiewicz U, Ciabarra A, Clemmons E, Cohen D, Cohen R, Cohen I, Concha M, Costell B, Crimmins D, Cruz-pagan Y, Cueli A, Cupelo R, Czarnecki M, Darby D, Dautzenberg Plj, De\u00a0Deyn P, De\u00a0La\u00a0Gandara J, Deck K, Dibenedetto D, Dibuono M, Dinnerstein E, Dirican A, Dixit S, Dobryniewski J, Drake R, Drysdale P, Duara R, Duffy J, Ellenbogen A, Faradji V, Feinberg M, Feldman R, Fishman S, Flitman S, Forchetti C, Fraga I, Frank A, Frishberg B, Fujigasaki H, Fukase H, Fumero I, Furihata K, Galloway C, Gandhi R, George K, Germain M, Gitelman D, Goetsch N, Goldfarb D, Goldstein M, Goldstick L, Gonzalez\u00a0Rojas Y, Goodman I, Greeley D, Griffin C, Grigsby E, Grosz D, Hafner K, Hart D, Henein S, Herskowitz B, Higashi S, Higashi Y, Ho G, Hodgson J, Hohenberg M, Hollenbeck L, Holub R, Hori T, Hort J, Ilkowski J, Ingram KJ, Isaac M, Ishikawa M, Janu L, Johnston M, Julio W, Justiz W, Kaga T, Kakigi T, Kalafer M, Kamijo M, Kaplan J, Karathanos M, Katayama S, Kaul S, Keegan A, Kerwin D, Khan U, Khan A, Kimura N, Kirk G, Klodowska G, Kowa H, Kutz C, Kwentus J, Lai R, Lall A, Lawrence M, Lee E, Leon R, Linker G, Lisewski P, Liss J, Liu C, Losk S, Lukaszyk E, Lynch J, Macfarlane S, Macsweeney J, Mannering N, Markovic O, Marks D, Masdeu J, Matsui Y, Matsuishi K, Mcallister P, Mcconnehey B, Mcelveen A, Mcgill L, Mecca A, Mega M, Mensah J, Mickielewicz A, Minaeian A, Mocherla B, Murphy C, Murphy P, Nagashima H, Nair A, Nair M, Nardandrea J, Nash M, Nasreddine Z, Nishida Y, Norton J, Nunez L, Ochiai J, Ohkubo T, Okamura Y, Okorie E, Olivera E, O\u2019mahony J, Omidvar O, Ortiz-Cruz D, Osowa A, Papka M, Parker A, Patel P, Patel A, Patel M, Patry C, Peckham E, Pfeffer M, Pietras A, Plopper M, Porsteinsson A, Poulin\u00a0Robitaille R, Prins N, Puente O, Ratajczak M, Rhee M, Ritter A, Rodriguez R, Rodriguez\u00a0Ables L, Rojas J, Ross J, Royer P, Rubin J, Russell D, Rutgers SM, Rutrick S, Sadowski M, Safirstein B, Sagisaka T, Scharre D, Schneider L, Schreiber C, Schrift M, Schulz P, Schwartz H, Schwartzbard J, Scott Ja. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023:330(6):512. https:\/\/doi.org\/10.1001\/jama.2023.13239","DOI":"10.1001\/jama.2023.13239"},{"issue":"11","key":"7885_CR15","doi-asserted-by":"publisher","first-page":"70997","DOI":"10.1002\/alz.70997","volume":"21","author":"R La Joie","year":"2025","unstructured":"La Joie R, Cummings JL, Dage JL, Galasko D, Ikonomovic MD, Karikari TK, et al. Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies. Alzheimer\u2019s & Dementia. 2025;21(11):70997. https:\/\/doi.org\/10.1002\/alz.70997.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"2","key":"7885_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.14283\/jpad.2022.21","volume":"9","author":"J Barakos","year":"2022","unstructured":"Barakos J, Purcell D, Suhy J, Chalkias S, Burkett P, Grassi CM, et al. Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with anti-amyloid beta therapy. J Prevent Alzheimer\u2019s Disease. 2022;9(2):211\u201320. https:\/\/doi.org\/10.14283\/jpad.2022.21.","journal-title":"J Prevent Alzheimer\u2019s Disease"},{"issue":"2","key":"7885_CR17","doi-asserted-by":"publisher","first-page":"70098","DOI":"10.1002\/trc2.70098","volume":"11","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Zhou Y, Lee G, Zhong K, Fonseca J, Leisgang-Osse AM, et al. Alzheimer\u2019s disease drug development pipeline: 2025. Alzheimer\u2019s & Dementia Transl Res Clin Intervent. 2025;11(2):70098. https:\/\/doi.org\/10.1002\/trc2.70098.","journal-title":"Alzheimer\u2019s & Dementia Transl Res Clin Intervent"},{"key":"7885_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40658-023-00569-0","volume":"10","author":"G Krokos","year":"2023","unstructured":"Krokos G, MacKewn J, Dunn J, Marsden P. A review of PET attenuation correction methods for PET-MR. EJNMMI Phys. 2023;10:52. https:\/\/doi.org\/10.1186\/s40658-023-00569-0.","journal-title":"EJNMMI Phys"},{"key":"7885_CR19","doi-asserted-by":"publisher","unstructured":"...Catana C, Laforest R, An H, Boada F, Cao T, Faul D, et al. A path to qualification of PET\/MRI scanners for multicenter brain imaging studies: Evaluation of MRI-based attenuation correction methods using a patient phantom. J Nucl Med. 2022;63(4):615\u201321. https:\/\/doi.org\/10.2967\/jnumed.120.261881. Publisher: Society of Nuclear Medicine Section: Special Contribution. Accessed 19 Oct 2025.","DOI":"10.2967\/jnumed.120.261881"},{"issue":"5","key":"7885_CR20","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/mp.15596","volume":"49","author":"PJ Markiewicz","year":"2022","unstructured":"Markiewicz PJ, Costa-Luis C, Dickson J, Barnes A, Krokos G, MacKewn J, et al. Advanced quantitative evaluation of PET systems using the ACR phantom and NiftyPET software. Med Phys. 2022;49(5):3298\u2013313. https:\/\/doi.org\/10.1002\/mp.15596.","journal-title":"Med Phys"},{"issue":"12","key":"7885_CR21","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.2967\/jnumed.116.175398","volume":"57","author":"T Sekine","year":"2016","unstructured":"Sekine T, Ter Voert EEGW, Warnock G, Buck A, Huellner M, Veit-Haibach P, et al. Clinical evaluation of zero-echo-time attenuation correction for brain 18F-FDG PET\/MRI: Comparison with atlas attenuation correction. J Nuclear Med Official Publ Soc Nuclear Med. 2016;57(12):1927\u201332. https:\/\/doi.org\/10.2967\/jnumed.116.175398.","journal-title":"J Nuclear Med Official Publ Soc Nuclear Med"},{"key":"7885_CR22","doi-asserted-by":"publisher","unstructured":"Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, et al. A multi-centre evaluation of eleven clinically feasible brain PET\/MRI attenuation correction techniques using a large cohort of patients. Neuroimage. 2017;147:346\u201359. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.12.010.","DOI":"10.1016\/j.neuroimage.2016.12.010"},{"key":"7885_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41824-019-0070-6","volume":"4","author":"MO Mada","year":"2020","unstructured":"Mada MO, Hindmarch P, Stirling J, Davies J, Brian D, Barnes A, et al. Competencies and training of radiographers and technologists for PET\/MR imaging - a study from the UK MR-PET network. Eur J Hybrid Imaging. 2020;4:1. https:\/\/doi.org\/10.1186\/s41824-019-0070-6.","journal-title":"Eur J Hybrid Imaging"},{"key":"7885_CR24","doi-asserted-by":"publisher","unstructured":"Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, et al. Amyloid imaging with 18F-Florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52(8):1210\u20137. https:\/\/doi.org\/10.2967\/jnumed.111.089730. Publisher: Society of Nuclear Medicine Section: Clinical Investigations. Accessed 18 Oct 2025.","DOI":"10.2967\/jnumed.111.089730"},{"key":"7885_CR25","doi-asserted-by":"publisher","unstructured":"Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, Adler LP, Kovnat KD, Seibyl JP, Arora A, Saha K, Burns JD, Lowrey MJ, Mintun MA, Skovronsky DM, Investigators tFFS. Performance characteristics of amyloid PET with Florbetapir F 18 in patients with Alzheimer\u2019s disease and cognitively normal subjects. J Nucl Med. 2012;53(3):378\u2013384. https:\/\/doi.org\/10.2967\/jnumed.111.090340.Publisher: Society of Nuclear Medicine Section: Clinical Investigations. Accessed 24 Nov 2025","DOI":"10.2967\/jnumed.111.090340."},{"issue":"3","key":"7885_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12149-017-1154-7","volume":"31","author":"T Miki","year":"2017","unstructured":"Miki T, Shimada H, Kim J-S, Yamamoto Y, Sugino M, Kowa H, et al. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer\u2019s disease, subjects with amnestic mild cognitive impairment and healthy volunteers. Ann Nucl Med. 2017;31(3):260\u201372. https:\/\/doi.org\/10.1007\/s12149-017-1154-7.","journal-title":"Ann Nucl Med"},{"key":"7885_CR27","doi-asserted-by":"publisher","unstructured":"Velasquez LM, Boellaard R, Kollia G, Hayes W, Hoekstra OS, Lammertsma AA, et al. Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies. J Nucl Med. 2009;50(10):1646\u201354. https:\/\/doi.org\/10.2967\/jnumed.109.063347. Publisher: Society of Nuclear Medicine Section: CLINICAL INVESTIGATIONS. Accessed 16 Jan 2026.","DOI":"10.2967\/jnumed.109.063347"},{"issue":"5","key":"7885_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2967\/jnumed.111.095299","volume":"53","author":"AJ De Langen","year":"2012","unstructured":"De Langen AJ, Vincent A, Velasquez LM, Van Tinteren H, Boellaard R, Shankar LK, et al. Repeatability of$$^{\\rm 18 }$$ F-FDG uptake measurements in tumors: A metaanalysis. J Nucl Med. 2012;53(5):701\u20138. https:\/\/doi.org\/10.2967\/jnumed.111.095299.","journal-title":"J Nucl Med"},{"key":"7885_CR29","doi-asserted-by":"publisher","unstructured":"Gutschmayer S, Yu J, Geist BK, \u00d6zer \u00d6, Reiterits B, Ferrara D, Pires M, Rausch I, Ibeschitz H, Karanikas G, Sundar LKS, Nics L, Chalampalakis Z, Muin D, Langsteger W, Hacker M, Beyer T. Whole-Body [18F]FDG-PET\/CT imaging of healthy controls: Test\/retest data for systemic, Multi-Organ Analysis. Sci Data. 2025;12(1):1707. https:\/\/doi.org\/10.1038\/s41597-025-05997-4.Publisher: Nature Publishing Group. Accessed 2026-01-16","DOI":"10.1038\/s41597-025-05997-4."},{"key":"7885_CR30","doi-asserted-by":"publisher","unstructured":"Delso G, F\u00fcrst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the siemens mMR integrated whole-body PET\/MR scanner. J Nucl Med. 2011;52(12):1914\u201322. https:\/\/doi.org\/10.2967\/jnumed.111.092726. Publisher: Society of Nuclear Medicine Section: Basic Science Investigations. Accessed 20 Aug 2025.","DOI":"10.2967\/jnumed.111.092726"},{"issue":"5","key":"7885_CR31","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1118\/1.4945416","volume":"43","author":"AM Grant","year":"2016","unstructured":"Grant AM, Deller TW, Khalighi MM, Maramraju SH, Delso G, Levin CS. NEMA NU 2\u20132012 performance studies for the SiPM-based ToF-PET component of the GE SIGNA PET\/MR system. Med Phys. 2016;43(5):2334\u201343. https:\/\/doi.org\/10.1118\/1.4945416.","journal-title":"Med Phys"},{"issue":"2","key":"7885_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"7885_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"key":"7885_CR34","doi-asserted-by":"publisher","unstructured":"Nelissen N, Laere KV, Thurfjell L, Owenius R, Vandenbulcke M, Koole M, et al. Phase 1 study of the pittsburgh compound B derivative 18F-Flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med. 2009;50(8):1251\u20139. https:\/\/doi.org\/10.2967\/jnumed.109.063305. Publisher: Society of Nuclear Medicine Section: CLINICAL INVESTIGATIONS. Accessed 21 Aug 2025.","DOI":"10.2967\/jnumed.109.063305"},{"key":"7885_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nicl.2017.04.025","volume":"15","author":"S Bullich","year":"2017","unstructured":"Bullich S, Seibyl J, Catafau AM, Jovalekic A, Koglin N, Barthel H, et al. Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment. NeuroImage Clinical. 2017;15:325\u201332. https:\/\/doi.org\/10.1016\/j.nicl.2017.04.025.","journal-title":"NeuroImage Clinical"},{"key":"7885_CR36","doi-asserted-by":"publisher","unstructured":"Koesters T, Friedman KP, Fenchel M, Zhan Y, Hermosillo G, Babb J, et al. Dixon sequence with superimposed model-based bone compartment provides highly accurate PET\/MR attenuation correction of the brain. J Nucl Med. 2016;57(6):918\u201324. https:\/\/doi.org\/10.2967\/jnumed.115.166967. Publisher: Society of Nuclear Medicine Section: Clinical Investigations. Accessed 21 Jan 2026.","DOI":"10.2967\/jnumed.115.166967"},{"key":"7885_CR37","doi-asserted-by":"publisher","unstructured":"Vandenberghe R, Laere KV, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Ann Neurol. 2010;68(3):319\u201329. https:\/\/doi.org\/10.1002\/ana.22068. Publisher: John Wiley & Sons, Ltd., Accessed 21 Aug 2025.","DOI":"10.1002\/ana.22068"},{"issue":"5","key":"7885_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz H-J, Dresel S, Peters O, Bartenstein P, Buerger K, et al. Cerebral amyloid-$$\\beta $$ PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10(5):424\u201335. https:\/\/doi.org\/10.1016\/S1474-4422(11)70077-1.","journal-title":"Lancet Neurol"},{"key":"7885_CR39","doi-asserted-by":"publisher","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem. Medica. 2012;276\u2013282. https:\/\/doi.org\/10.11613\/BM.2012.031.","DOI":"10.11613\/BM.2012.031"},{"issue":"9","key":"7885_CR40","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/jamaneurol.2025.2218","volume":"82","author":"E Zeltzer","year":"2025","unstructured":"Zeltzer E, Schonhaut DR, Mundada NS, Blazhenets G, Soleimani-Meigooni DN, Cho H, et al. Concordance between Amyloid-PET quantification and real-world visual reads. JAMA Neurol. 2025;82(9):952\u201362. https:\/\/doi.org\/10.1001\/jamaneurol.2025.2218.","journal-title":"JAMA Neurol"},{"key":"7885_CR41","doi-asserted-by":"publisher","first-page":"103765","DOI":"10.1016\/j.nicl.2025.103765","volume":"46","author":"L Iaccarino","year":"2025","unstructured":"Iaccarino L, Burnham SC, Tunali I, Wang J, Navitsky M, Arora AK, et al. A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research. NeuroImage Clin. 2025;46:103765. https:\/\/doi.org\/10.1016\/j.nicl.2025.103765.","journal-title":"NeuroImage Clin"},{"issue":"1","key":"7885_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, et al. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET. Alzheimer\u2019s & Dementia. 2015;11(1):1\u2013154. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"2","key":"7885_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"J Chiropr Med"},{"key":"7885_CR44","doi-asserted-by":"publisher","unstructured":"Bland JM, Altman DG. Statistics Notes: Measurement error. BMJ. 1996;313(7059):744. https:\/\/doi.org\/10.1136\/bmj.313.7059.744 . Publisher: British Medical Journal Publishing Group Section: Education and debate. Accessed 22 Dec 2025.","DOI":"10.1136\/bmj.313.7059.744"},{"issue":"1","key":"7885_CR45","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.tjpad.2024.100008","volume":"12","author":"G Farrar","year":"2025","unstructured":"Farrar G, Weber CJ, Rabinovici GD. Expert opinion on Centiloid thresholds suitable for initiating anti-amyloid therapy. Summary of discussion at the 2024 spring Alzheimer\u2019s Association Research Roundtable. J Prevent Alzheimer\u2019s Disease. 2025;12(1):100008. https:\/\/doi.org\/10.1016\/j.tjpad.2024.100008.","journal-title":"J Prevent Alzheimer\u2019s Disease"},{"key":"7885_CR46","doi-asserted-by":"publisher","unstructured":"Bullich S, Villemagne VL, Catafau AM, Jovalekic A, Koglin N, Rowe CC, et al. Optimal reference region to measure longitudinal amyloid-$$\\beta $$ change with 18F-Florbetaben PET. J Nucl Med. 2017;58(8):1300\u20136. https:\/\/doi.org\/10.2967\/jnumed.116.187351. Publisher: Society of Nuclear Medicine Section: Neurology. Accessed 26 Nov 2025.","DOI":"10.2967\/jnumed.116.187351"},{"issue":"1","key":"7885_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13550-020-00714-1","volume":"10","author":"F Heeman","year":"2020","unstructured":"Heeman F, Hendriks J, Lopes Alves I, Ossenkoppele R, Tolboom N, Berckel BNM, et al. on behalf of the AMYPAD Consortium: [11C]PIB amyloid quantification: effect of reference region selection. EJNMMI Res. 2020;10(1):123. https:\/\/doi.org\/10.1186\/s13550-020-00714-1.","journal-title":"EJNMMI Res"},{"issue":"1","key":"7885_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40658-020-00295-x","volume":"7","author":"JE Mackewn","year":"2020","unstructured":"Mackewn JE, Stirling J, Jeljeli S, Gould S-M, Johnstone RI, Merida I, et al. Practical issues and limitations of brain attenuation correction on a simultaneous PET-MR scanner. EJNMMI Phys. 2020;7(1):24. https:\/\/doi.org\/10.1186\/s40658-020-00295-x.","journal-title":"EJNMMI Phys"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07885-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:54:14Z","timestamp":1781650454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07885-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7885"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07885-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded primarily by an UK MRC partnership grant (MR\/N025792\/1); for other personal funding details see Acknowledgements above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"See Acknowledgements above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"The study was approved by the NHS Health Research Authority (\n                      \n                      ) ethics committee (Ref: 18\/NW\/0102; IRAS 223411) and the UK Administration of Radioactive Substances Advisory Committee (\n                      \n                      ). See Supplementary Information Section\u00a0\n                      \n                      for details.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}